Navigation Links
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Date:6/3/2008

he European molecular diagnostics market, which we estimate is growing at roughly double the rate of the U.S. market," said Hank Nordhoff, Gen-Probe's chairman and chief executive officer. "In addition, the proposed acquisition would provide access to a number of complementary products, technologies and markers that are generating revenue today or that we believe could be commercialized in the future."

Gen-Probe's offer represents a 7% premium to Innogenetics' per share closing price of EUR 5.71 on June 2, 2008, a 6% premium to the conditional EUR 5.75 per share offer made by Solvay Pharmaceuticals S.A. on April 25, 2008, and a 41% premium to Innogenetics' unaffected average share price of EUR 4.33 in the three months prior to the announcement of Solvay's offer.

"We believe our offer represents full and fair value for all Innogenetics shareholders, while providing additional value over the offer recently made by Solvay," Nordhoff said. "Moreover, we believe Gen-Probe's well-established expertise and track record in molecular diagnostics would offer Innogenetics' customers and employees the best opportunity for long-term success."

Innogenetics' key diagnostic products include CE-marked genotyping assays for infectious diseases such as hepatitis C and B, and human papillomavirus (HPV). The company also sells genetic tests for cystic fibrosis and tests for human leukocyte antigens (HLA) that are used to establish tissue compatibility in organ transplants. Innogenetics recently received CE marking for its first assay on its new "4-MAT" microarray platform. Innogenetics holds a PCR license from Roche and an xMAP(R) multiplex technology license from Luminex. Innogenetics recently announced a restructuring and closure of its therapeutics subsidiary, GENimmune, in order to focus on diagnostics product opportunities.

Gen-Probe has filed a draft takeover prospectus with the CBFA, Belgium's Banking, Finance and Insurance Commission. The proposed acq
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprestig...n,sleadingonlinejobboardandcareerssiteforlifescien...ersityarenowmembersofthejobboard,joining28othermaj...rd, www.biocareercenter.com ,isonlyforpost-graduat...encecareersitesontheInternet,BioCareerCenteristheo...
(Date:11/24/2009)...T.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Aldric...SDAQOMXconferenceonTuesday,December1stat1:45PMGMTi...liveaudiobroadcastovertheInternetavailableat http...anclickthe"Webcast"icontoaccessthisfile. ,, A...enceandHighTechnologycompany.Itschemicalandbiochem...
(Date:11/24/2009)...HANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceutical...)hasallowedthepatentapplicationfor,itsnano-particl...isahighlyefficientapproachtoincorporatepeptidesor,...deliveryofdrugs,otherwiseadministeredasinjections....dtomanymacromoleculardrugssuchasinsulin,interferon...
(Date:11/24/2009)...EATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.an...pmentAuthority(OPDA)wererecentlyawarded$2millionby...ard(CERB)inaprivate/publicpartnershiptoconstructth...olnCounty,WA. ,, "Thisinvestmentwillsignificant...0greenjobstoLincolnCounty,"saidBlueMarbleEnergyCEO...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...Buinevicius, the first wave of streaming media was...ns in sports and entertainment; but by and large, ...media is now shifting from entertainment to being ... and the information experience. Just like the Int...tions and educational institutions are beginning t...
...isaster recovery techniques, such as off-site tape...ve full recovery, Ready Recovery provides nearly r...ystem mirroring technology, said Paul Shain, presi...om-built products based on best practices gathered...tion can help organizations reduce complexity in t...
... U.S. Representative Tammy Baldwin (D-WI) has anno...nding as part of the fiscal budget to the UW-Rock ...used to upgrade computers and lab equipment for st... and other healthcare related fields. , ,I know th...ntys economic development, Baldwin said. This scho...
Other Biology Technology:Congresswoman Baldwin secures Federal Funds for UW-Rock County 2
(Date:11/25/2009)... the heart pumps some 250 million liters of blood ...cle fibers of the heart have to be extremely durab...bauer, vice chair of the Department of Medicine II...f. Dr. H. A. Katus), has discovered a protein that...muscular unit, the sarcomere. In cooperation with ...
(Date:11/24/2009)...LRI) today named 12 new grant recipients for 2009....vative work across a broad spectrum of lupus resea...ty, and potential to drive scientific discovery to...isease of systemic lupus. , The 2009 grants go t...s the nation and include interdisciplinary and hig...
(Date:11/24/2009)...emarkable class of ring-shaped protein motors has ...rkeley National Laboratory (Berkeley Lab) using a ...at the Advanced Light Source (ALS). These protein ...eplication, and are vital to the survival of all b...h as the human papillomavirus, which has been link...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 1Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 2Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 3Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 1Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 2Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 3Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 5Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 6Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 7Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 8Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 9Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 10Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 11Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 12Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 13Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 14Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 15Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 16Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 17Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 18Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 19Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 20Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 21Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 22Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 23Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 24Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 25Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 26Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 27Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 28Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 29VIVUS Announces Promotion of Peter Tam to President 5941 1VIVUS Announces Promotion of Peter Tam to President 5941 2VIVUS Announces Promotion of Peter Tam to President 5941 3
...ence Foundation have launched a key initiative to ...ine; broadly defined as the development of stem ce...ells and tissues in the human body. , Stem cells ...en programmed to perform a specific function. Most...it is becoming clear that if these cells can be gi...
...letin Board: BMRX) a leading developer of finger r... the Handgun Club of America has endorsed the,Comp...g great interest in,bioMETRX,s smartTOUCH(TM) bioV...o stored firearms with the touch of a finger, and ...es can be used for controlled access,of handguns, ...
... Davis faculty member has resolved a longstanding ...ar more accurate predictions of global climate cha...lished online Wednesday (June 18) by the journal ...s of the nitrogen cycle in temperate and tropical ...capable of extracting nitrogen directly from the a...
Other Biology News:European Science Foundation aims to strengthen 'regenerative medicine' 2bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America 2bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America 3UC Davis researcher leads climate-change discovery 2
BLOCK-iT Adenoviral RNAi Expression System from Invitrogen
pCC1BAC/plndigoBAC-5 Reverse Sequencing Primer from EPICENTRE Biotechnologies
...s ,,GenScript offers many antibody modific...ibody fragmentation. Labeling antibodies with biot...quantitation of the target molecule. In some assay...g (Fab) portion of the antibody. For these applica...
Protein Tyrosine Phosphatase 1B Colorimetric Assay Kit from Calbiochem
Biology Products: